Resource Materials for Implementation of Meningococcal Immunization Recommendations for Adolescents and Young Adults.
Practice Resources
S.T.O.P. Meningitis! is a program sponsored by the National Foundation for Infectious Diseases (NFID) in collaboration with several of the nation’s leading medical and advocacy groups to provide helpful information to clinicians and other health care providers who care for adolescents and young adults. S.T.O.P. stands for Share. Teach. Outreach. Protect.
This program supports the Centers for Disease Control and Prevention (CDC) recommendations that call for routine immunization among all adolescents 11-18 years of age to prevent meningococcal disease.
NFID collaborated with the American Academy of Family Physicians, American Academy of Pediatrics, American College Health Association, American College of Physicians, American Medical Association, Society for Adolescent Medicine and National Meningitis Association to develop this program.
The goals of the S.T.O.P. Meningitis! resource kit are to:
The goals of the S.T.O.P. Meningitis! program are supported by the CDC.
Practice Resources
S.T.O.P. Meningitis! is a program sponsored by the National Foundation for Infectious Diseases (NFID) in collaboration with several of the nation’s leading medical and advocacy groups to provide helpful information to clinicians and other health care providers who care for adolescents and young adults. S.T.O.P. stands for Share. Teach. Outreach. Protect.
This program supports the Centers for Disease Control and Prevention (CDC) recommendations that call for routine immunization among all adolescents 11-18 years of age to prevent meningococcal disease.
NFID collaborated with the American Academy of Family Physicians, American Academy of Pediatrics, American College Health Association, American College of Physicians, American Medical Association, Society for Adolescent Medicine and National Meningitis Association to develop this program.
The goals of the S.T.O.P. Meningitis! resource kit are to:
|
To date, there is insufficient evidence to conclude meningococcal vaccination may be linked to Guillian-Barré Syndrome. CDC/FDA continue to recommend adolescent vaccination with the quadrivalent (A, C, Y, and W135) meningococcal conjugate vaccine since an ongoing known risk for serious meningococcal disease exists. |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
